{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:29:54Z","timestamp":1792783794086,"version":"4.5.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Wadsworth Foundation Peter Rowley Breast Cancer Grant","award":["55705"],"award-info":[{"award-number":["55705"]}]},{"name":"New York State Council of Health-system Pharmacists, Research and Education Foundation Oncology Leadership Grant","award":["50151"],"award-info":[{"award-number":["50151"]}]},{"name":"New York State Council of Health-system Pharmacists, Research and Education Foundation Clinical Pharmacy Award","award":["53967"],"award-info":[{"award-number":["53967"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.cyto.2016.10.017","type":"journal-article","created":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T22:15:51Z","timestamp":1480544151000},"page":"45-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Insulin use, adipokine profiles and breast cancer prognosis"],"prefix":"10.1016","volume":"89","author":[{"given":"Zachary A.P.","family":"Wintrob","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey P.","family":"Hammel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thaer","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George K.","family":"Nimako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Wei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra S.","family":"Fayazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan P.","family":"Gaile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice C.","family":"Ceacareanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cyto.2016.10.017_b0005","doi-asserted-by":"crossref","first-page":"S823","DOI":"10.1093\/ajcn\/86.3.823S","article-title":"Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence","volume":"86","author":"Xue","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.cyto.2016.10.017_b0010","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1023\/B:CACO.0000024225.14618.a8","article-title":"Hyperinsulinaemia and increased risk of breast cancer: findings from the British Women\u2019s Heart and Health Study","volume":"15","author":"Lawlor","year":"2004","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.cyto.2016.10.017_b0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1196\/annals.1372.039","article-title":"Inflammatory process in type 2 diabetes: the role of cytokines","volume":"1084","author":"Alexandraki","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.cyto.2016.10.017_b0020","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/bcr1746","article-title":"Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression","volume":"9","author":"DeNardo","year":"2007","journal-title":"Breast Cancer Res."},{"issue":"2","key":"10.1016\/j.cyto.2016.10.017_b0025","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1677\/erc.1.00729","article-title":"Molecular links between obesity and breast cancer","volume":"13","author":"Lorincz","year":"2006","journal-title":"Endocr. Relat. Cancer"},{"issue":"2","key":"10.1016\/j.cyto.2016.10.017_b0030","doi-asserted-by":"crossref","first-page":"R34","DOI":"10.1186\/bcr2856","article-title":"Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study","volume":"13","author":"Oh","year":"2011","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.cyto.2016.10.017_b0035","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv320","article-title":"RE: circulating adipokines and inflammatory markers and postmenopausal breast cancer risk","volume":"108","author":"Wion-Barbot","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.cyto.2016.10.017_b0040","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/678756","article-title":"Use of insulin and mortality from breast cancer among Taiwanese women with diabetes","volume":"2015","author":"Tseng","year":"2015","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.cyto.2016.10.017_b0045","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.2823","article-title":"Type 2 diabetes, insulin treatment and prognosis of breast cancer","author":"Mu","year":"2016","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.cyto.2016.10.017_b0050","doi-asserted-by":"crossref","DOI":"10.1177\/0897190015627255","article-title":"Synergistic benefit of statin and metformin in gastrointestinal malignancies","author":"Nimako","year":"2016","journal-title":"J. Pharm. Pract."},{"issue":"3","key":"10.1016\/j.cyto.2016.10.017_b0055","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv006","article-title":"Effect of metformin vs placebo on and metabolic factors in NCIC CTG MA.32","volume":"107","author":"Goodwin","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.cyto.2016.10.017_b0060","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1210\/er.2011-1015","article-title":"The role of adiponectin in cancer: a review of current evidence","volume":"33","author":"Dalamaga","year":"2012","journal-title":"Endocr. Rev."},{"issue":"10","key":"10.1016\/j.cyto.2016.10.017_b0065","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1158\/1055-9965.EPI-09-0372","article-title":"Obesity and cancer: the role of dysfunctional adipose tissue","volume":"18","author":"van Kruijsdijk","year":"2009","journal-title":"Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"issue":"3","key":"10.1016\/j.cyto.2016.10.017_b0070","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/dmrr.923","article-title":"Association between C-reactive protein and pre-diabetic status in a Chinese Han clinical population","volume":"25","author":"Lin","year":"2009","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"2","key":"10.1016\/j.cyto.2016.10.017_b0075","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/dmrr.679","article-title":"Plasma interleukin-6 levels are increased in subjects with impaired glucose tolerance but not in those with impaired fasting glucose in a cohort of Italian Caucasians","volume":"23","author":"Cardellini","year":"2007","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"9","key":"10.1016\/j.cyto.2016.10.017_b0080","first-page":"11587","article-title":"Serum cytokine, chemokine and hormone levels in Saudi adults with pre-diabetes: a one-year prospective study","volume":"8","author":"Al-Daghri","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"12","key":"10.1016\/j.cyto.2016.10.017_b0085","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue","volume":"112","author":"Weisberg","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.cyto.2016.10.017_b0090","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10549-006-9328-3","article-title":"Significance of interleukin-6 (IL-6) in breast cancer (review)","volume":"102","author":"Knupfer","year":"2007","journal-title":"Breast Cancer Res. Treat."},{"issue":"48","key":"10.1016\/j.cyto.2016.10.017_b0095","first-page":"82","article-title":"Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients","volume":"2003","author":"Koz\u0142owski","year":"1995","journal-title":"Rocz. Akad. Med. Bialymst."},{"issue":"3","key":"10.1016\/j.cyto.2016.10.017_b0100","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4048\/jbc.2015.18.3.264","article-title":"Association between metformin therapy and breast cancer incidence and mortality: evidence from a meta-analysis","volume":"18","author":"Yang","year":"2015","journal-title":"J. Breast Cancer"},{"issue":"9","key":"10.1016\/j.cyto.2016.10.017_b0105","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1158\/1940-6207.CAPR-13-0424","article-title":"Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders","volume":"7","author":"Gandini","year":"2014","journal-title":"Cancer Prev. Res. (Phila)"},{"issue":"8","key":"10.1016\/j.cyto.2016.10.017_b0110","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/dom.12267","article-title":"The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis","volume":"16","author":"Zhang","year":"2014","journal-title":"Diabetes Obes. Metab."},{"issue":"6","key":"10.1016\/j.cyto.2016.10.017_b0115","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1515\/JPM.2007.123","article-title":"Plasma adiponectin concentrations in non-pregnant, normal and overweight pregnant women","volume":"35","author":"Nien","year":"2007","journal-title":"J. Perinat. Med."},{"issue":"6","key":"10.1016\/j.cyto.2016.10.017_b0120","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/01.ATV.20.6.1595","article-title":"Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients","volume":"20","author":"Hotta","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"15","key":"10.1016\/j.cyto.2016.10.017_b0125","first-page":"5699","article-title":"Association of serum adiponectin levels with breast cancer risk","volume":"9","author":"Miyoshi","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.cyto.2016.10.017_b0130","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia","volume":"86","author":"Weyer","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.cyto.2016.10.017_b0135","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1530\/eje.0.1490331","article-title":"Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance","volume":"149","author":"Silha","year":"2003","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"10.1016\/j.cyto.2016.10.017_b0140","first-page":"170","article-title":"Variation of adiponectin levels in normal and obese subjects: possible correlation with lipid profiles","volume":"7","author":"Mamaghani","year":"2009","journal-title":"Int. J. Endocrinol. Metab."},{"issue":"19","key":"10.1016\/j.cyto.2016.10.017_b0145","doi-asserted-by":"crossref","first-page":"8325","DOI":"10.7314\/APJCP.2014.15.19.8325","article-title":"Relation of serum adiponectin levels and obesity with breast cancer: a Japanese case-control study","volume":"15","author":"Minatoya","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"3","key":"10.1016\/j.cyto.2016.10.017_b0150","first-page":"787","article-title":"Adiponectin effects on human breast cancer cells are dependent on 17-beta estradiol","volume":"19","author":"Pfeiler","year":"2008","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.cyto.2016.10.017_b0155","doi-asserted-by":"crossref","first-page":"e4968","DOI":"10.1371\/journal.pone.0004968","article-title":"Adiponectin haploinsufficiency promotes mammary tumor development in MMTV-PyVT mice by modulation of phosphatase and tensin homolog activities","volume":"4","author":"Lam","year":"2009","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cyto.2016.10.017_b0160","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1210\/jcem.87.5.8450","article-title":"Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro","volume":"87","author":"Bastard","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.cyto.2016.10.017_b0165","first-page":"245","article-title":"Serum leptin values in the healthy obese and non-obese subjects of Rawalpindi","volume":"63","author":"Kazmi","year":"2013","journal-title":"J. Pak. Med. Assoc."},{"issue":"2","key":"10.1016\/j.cyto.2016.10.017_b0170","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1055\/s-2003-39054","article-title":"Leptin levels in type 2 diabetes: associations with measures of insulin resistance and insulin secretion","volume":"35","author":"Wauters","year":"2003","journal-title":"Horm. Metab. Res."},{"issue":"6","key":"10.1016\/j.cyto.2016.10.017_b0175","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.clbc.2013.08.001","article-title":"Insulin and leptin levels in obese patients with and without breast cancer","volume":"13","author":"Romero-Figueroa Mdel","year":"2013","journal-title":"Clin. Breast Cancer"},{"issue":"2","key":"10.1016\/j.cyto.2016.10.017_b0180","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s10753-011-9361-1","article-title":"Association between C-reactive protein and type 2 diabetes in a Tunisian population","volume":"35","author":"Belfki","year":"2012","journal-title":"Inflammation"},{"issue":"6","key":"10.1016\/j.cyto.2016.10.017_b0185","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1210\/jc.2008-2754","article-title":"High-sensitivity C-reactive protein levels and type 2 diabetes in urban North Indians","volume":"94","author":"Mahajan","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.cyto.2016.10.017_b0190","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jama.286.3.327","article-title":"C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus","volume":"286","author":"Pradhan","year":"2001","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.cyto.2016.10.017_b0195","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2337\/diabetes.52.3.812","article-title":"Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study","volume":"52","author":"Spranger","year":"2003","journal-title":"Diabetes"},{"issue":"21","key":"10.1016\/j.cyto.2016.10.017_b0200","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1200\/JCO.2008.18.9068","article-title":"Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients","volume":"27","author":"Pierce","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.cyto.2016.10.017_b0205","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1161\/01.ATV.19.4.972","article-title":"C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?","volume":"19","author":"Yudkin","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"10.1016\/j.cyto.2016.10.017_b0210","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/jnci\/djk202","article-title":"C-reactive protein and risk of breast cancer","volume":"99","author":"Zhang","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.cyto.2016.10.017_b0215","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3816\/CBC.2002.n.008","article-title":"Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients","volume":"2","author":"Benoy","year":"2002","journal-title":"Clin. Breast Cancer"},{"issue":"9","key":"10.1016\/j.cyto.2016.10.017_b0220","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/oby.2000.86","article-title":"Raised interleukin-6 levels in obese patients","volume":"8","author":"Roytblat","year":"2000","journal-title":"Obes. Res."},{"issue":"8","key":"10.1016\/j.cyto.2016.10.017_b0225","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1176\/appi.ajp.158.8.1252","article-title":"Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings","volume":"158","author":"Musselman","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.cyto.2016.10.017_b0230","doi-asserted-by":"crossref","first-page":"E745","DOI":"10.1152\/ajpendo.2001.280.5.E745","article-title":"Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance","volume":"280","author":"Kern","year":"2001","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.cyto.2016.10.017_b0235","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1023\/A:1005736712307","article-title":"Serum concentration of tumor necrosis factor in patients with breast cancer","volume":"43","author":"Sheen-Chen","year":"1997","journal-title":"Breast Cancer Res. Treat."},{"issue":"2","key":"10.1016\/j.cyto.2016.10.017_b0240","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/172460080401900207","article-title":"Serum levels of tumor necrosis factor alpha correlate with response to neoadjuvant chemotherapy in locally advanced breast cancer","volume":"19","author":"Berberoglu","year":"2004","journal-title":"Int. J. Biol. Markers"},{"issue":"1","key":"10.1016\/j.cyto.2016.10.017_b0245","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.cyto.2012.06.241","article-title":"Polymorphic variations in IL-1beta, IL-6 and IL-10 genes, their circulating serum levels and breast cancer risk in Indian women","volume":"60","author":"Pooja","year":"2012","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.cyto.2016.10.017_b0250","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.phrs.2006.11.002","article-title":"Interleukin-1 (IL-1) receptor antagonist gene polymorphism in normal weight obese syndrome: relationship to body composition and IL-1 alpha and beta plasma levels","volume":"55","author":"Di Renzo","year":"2007","journal-title":"Pharmacol. Res."},{"issue":"1 Pt 2","key":"10.1016\/j.cyto.2016.10.017_b0255","first-page":"R204","article-title":"IL-1 beta mediates leptin induction during inflammation","volume":"274","author":"Faggioni","year":"1998","journal-title":"Am. J. Physiol."},{"issue":"6","key":"10.1016\/j.cyto.2016.10.017_b0260","first-page":"1251","article-title":"Evidence for transcriptional activation of ERalpha by IL-1beta in breast cancer cells","volume":"15","author":"Speirs","year":"1999","journal-title":"Int. J. Oncol."},{"issue":"Suppl.","key":"10.1016\/j.cyto.2016.10.017_b0265","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.2337\/dc15-S010","article-title":"(7) Approaches to glycemic treatment","volume":"38","author":"American Diabetes A.","year":"2015","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.cyto.2016.10.017_b0270","first-page":"140-+","article-title":"ACP updates guideline on oral pharmacologic treatments for type 2 diabetes mellitus","volume":"87","author":"Devitt","year":"2013","journal-title":"Am. Fam. Physician"},{"issue":"1","key":"10.1016\/j.cyto.2016.10.017_b0275","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4158\/EP151126.CS","article-title":"Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm - 2016 executive summary","volume":"22","author":"Garber","year":"2016","journal-title":"Endocr. Pract."},{"issue":"2","key":"10.1016\/j.cyto.2016.10.017_b0280","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10549-015-3331-5","article-title":"The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes","volume":"150","author":"Vissers","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"issue":"8","key":"10.1016\/j.cyto.2016.10.017_b0285","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s10552-015-0599-z","article-title":"Associations between diabetes medication use and risk of second breast cancer events and mortality","volume":"26","author":"Calip","year":"2015","journal-title":"Cancer Causes Control"},{"issue":"3","key":"10.1016\/j.cyto.2016.10.017_b0290","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/01.EPX.0000456620.00173.c0","article-title":"Metformin and survival in diabetic patients with breast cancer","volume":"89","author":"El-Benhawy","year":"2014","journal-title":"J. Egypt. Public Health Assoc."},{"issue":"7","key":"10.1016\/j.cyto.2016.10.017_b0295","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/annonc\/mdr534","article-title":"Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer","volume":"23","author":"He","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.cyto.2016.10.017_b0300","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/181240","article-title":"Type 2 diabetes mellitus, oral diabetic medications, insulin therapy, and overall breast cancer risk","volume":"2013","author":"Ahmadieh","year":"2013","journal-title":"ISRN Endocrinol."},{"issue":"4","key":"10.1016\/j.cyto.2016.10.017_b0305","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1007\/s12032-010-9572-6","article-title":"More favorable progesterone receptor phenotype of breast cancer in diabetics treated with metformin","volume":"28","author":"Berstein","year":"2011","journal-title":"Med. Oncol."},{"issue":"6","key":"10.1016\/j.cyto.2016.10.017_b0310","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1634\/theoncologist.2011-0462","article-title":"Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis","volume":"17","author":"Soranna","year":"2012","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.cyto.2016.10.017_b0315","doi-asserted-by":"crossref","first-page":"782","DOI":"10.4158\/EP15612.OR","article-title":"Two treatment approaches for human regular U-500 insulin in patients with type 2 diabetes not achieving adequate glycemic control on high-dose U-100 insulin therapy with or without oral agents: a randomized, titration-to-target clinical trial","volume":"21","author":"Hood","year":"2015","journal-title":"Endocr. Pract.: Off. J. Am. Coll. Endocrinol. Am. Assoc. Clin. Endocrinol."},{"key":"10.1016\/j.cyto.2016.10.017_b0320","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-015-1876-7","article-title":"Prolonged use of human insulin increases breast cancer risk in Taiwanese women with type 2 diabetes","volume":"15","author":"Tseng","year":"2015","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.cyto.2016.10.017_b0325","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.1999.17.5.1474","article-title":"Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer","volume":"17","author":"Harvey","year":"1999","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.cyto.2016.10.017_b0330","doi-asserted-by":"crossref","first-page":"R6","DOI":"10.1186\/bcr1639","article-title":"Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients","volume":"9","author":"Dunnwald","year":"2007","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.cyto.2016.10.017_b0335","doi-asserted-by":"crossref","unstructured":"Z. Wintrob, J.P. Hammel, G.K. Nimako, Z.S. Fayazi, D.P. Gaile, A. Forrest, A.C. Ceacareanu, Circulating adipokines data associated with insulin secretagogue use in breast cancer patients, Data in Brief - submitted (in press).","DOI":"10.1016\/j.dib.2016.11.060"},{"issue":"2","key":"10.1016\/j.cyto.2016.10.017_b0340","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cyto.2014.02.011","article-title":"Sexual dimorphism, weight gain and glucose intolerance in a B- and T-cell deficient mouse model","volume":"67","author":"Wintrob","year":"2014","journal-title":"Cytokine"},{"issue":"6","key":"10.1016\/j.cyto.2016.10.017_b0345","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/obr.12281","article-title":"The integrative role of leptin, oestrogen and the insulin family in obesity-associated breast cancer: potential effects of exercise","volume":"16","author":"Schmidt","year":"2015","journal-title":"Obes. Rev."},{"issue":"6","key":"10.1016\/j.cyto.2016.10.017_b0350","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1530\/eje.0.1460839","article-title":"A pulse of insulin and dexamethasone stimulates serum leptin in fasting human subjects","volume":"146","author":"Laferrere","year":"2002","journal-title":"Eur. J. Endocrinol.\/Eur. Federation Endocr. Soc."},{"key":"10.1016\/j.cyto.2016.10.017_b0355","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13058-015-0622-z","article-title":"Leptin produced by obese adipose stromal\/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers","volume":"17","author":"Strong","year":"2015","journal-title":"Breast Cancer Res.: BCR"},{"issue":"1","key":"10.1016\/j.cyto.2016.10.017_b0360","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.biopha.2012.10.001","article-title":"Leptin attenuates the anti-estrogen effect of tamoxifen in breast cancer","volume":"67","author":"Chen","year":"2013","journal-title":"Biomed. Pharmacotherapy=Biomed. Pharmacotherapie"},{"issue":"3","key":"10.1016\/j.cyto.2016.10.017_b0365","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10549-013-2488-z","article-title":"The role of intratumoral and systemic IL-6 in breast cancer","volume":"138","author":"Dethlefsen","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"issue":"5","key":"10.1016\/j.cyto.2016.10.017_b0370","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ijc.10833","article-title":"Circulating interleukin-6 predicts survival in patients with metastatic breast cancer","volume":"103","author":"Salgado","year":"2003","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.cyto.2016.10.017_b0375","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1158\/1055-9965.EPI-07-0093","article-title":"Associations of circulating C-reactive protein and interleukin-6 with survival in women with and without cancer: findings from the British Women\u2019s Heart and Health Study","volume":"16","author":"Heikkila","year":"2007","journal-title":"Cancer Epidemiol. Biomark. Prevention: A Publication of the American Association for Cancer Research"},{"key":"10.1016\/j.cyto.2016.10.017_b0380","doi-asserted-by":"crossref","DOI":"10.1038\/srep10508","article-title":"C-reactive protein and risk of breast cancer: a systematic review and meta-analysis","volume":"5","author":"Guo","year":"2015","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.cyto.2016.10.017_b0385","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.3390\/cancers7040883","article-title":"The interactions of obesity, inflammation and insulin resistance in breast cancer","volume":"7","author":"Rose","year":"2015","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.cyto.2016.10.017_b0390","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1124\/pr.55.1.7","article-title":"Pharmacological agents that directly modulate insulin secretion","volume":"55","author":"Doyle","year":"2003","journal-title":"Pharmacol. Rev."},{"issue":"1\u20132","key":"10.1016\/j.cyto.2016.10.017_b0395","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2152\/jmi.53.87","article-title":"Efficacy of glimepiride on insulin resistance, adipocytokines, and atherosclerosis","volume":"53","author":"Koshiba","year":"2006","journal-title":"J. Med. Invest.: JMI"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466616305579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466616305579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T00:09:54Z","timestamp":1568592594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466616305579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":79,"alternative-id":["S1043466616305579"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2016.10.017","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin use, adipokine profiles and breast cancer prognosis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2016.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}